Last deal

$416.9K
Local Amount - GBP 330.K

Amount

Grant

Stage

04.12.2023

Date

5

all rounds

$4.9M

Total amount

General

About Company
CellulaREvolution develops cell culturing technology using self-assembling peptides.

Industry

Sector :

Subsector :

founded date

01.01.2018

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

The company's technology is designed to facilitate cell manufacturing in the fields of cultured meat, cell therapy, and biologics by developing a peptide coating that increases cell proliferation and bioreactor capable of serum-free continuous production. This enables cultured cell therapists and other biologics companies to eliminate serum from their production process and allows them to change from batch to continuous production. CellulaREvolution's scalable bioprocessing technology revolutionizes cell cultivation by developing an industry-first continuous process that enables more efficient and affordable cell proliferation. Their adherent cell culture technology delivers a significantly higher yield than incumbent batch processes, making it of critical importance in building a new equitable and sustainable food system and advancing cell therapy treatments.
Contacts